Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Female × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 159 Lymphoma 124 Lymphoma, Large B-Cell, Diffuse 72 Sarcoma 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 60 Hodgkin Disease 46 Lymphoma, Non-Hodgkin 45 Leukemia 37 Burkitt Lymphoma 37 Lymphoma, Mantle-Cell 35 Lymphoma, Follicular 33 Ovarian Neoplasms 26 Neuroblastoma 24 Neoplasms 24 Carcinoma, Hepatocellular 21 Multiple Myeloma 20 Lymphoma, Large-Cell, Anaplastic 20 Lymphoma, Large-Cell, Immunoblastic 19 HIV Infections 17 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 16 Acquired Immunodeficiency Syndrome 15 Urinary Bladder Neoplasms 14 Liposarcoma 14 Osteosarcoma 13 Leiomyosarcoma 13 Histiocytoma, Malignant Fibrous 13 Breast Neoplasms, Male 13 Sarcoma, Synovial 11 Neurofibrosarcoma 11

Interventions

Exercise 3 Paclitaxel 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Ropivacaine 1 Radiofrequency Ablation 1 Neoadjuvant Therapy 1 Methotrexate 1 Metformin 1 Mastectomy 1 Electrochemotherapy 1 Educational Status 1 Drug Delivery Systems 1 Doxorubicin 1 Diet 1 Dexmedetomidine 1 Control Groups 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04170465 2022-09-10

METNEO

Damanhour University

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡